Ignite Creation Date:
2024-05-06 @ 3:10 PM
Last Modification Date:
2024-10-26 @ 1:44 PM
Study NCT ID:
NCT04541628
Status:
TERMINATED
Last Update Posted:
2024-01-24
First Post:
2020-08-21
Brief Title:
Safety Efficacy of Encapsulated Allogeneic FVIII Cell Therapy in Haemophilia A
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-28
Start Date Type:
ACTUAL
Primary Completion Date:
2022-10-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-10-28
Completion Date Type:
ACTUAL
First Submit Date:
2020-08-21
First Submit QC Date:
September 1 2020
Study First Post Date:
2020-09-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-08
Last Update Post Date:
2024-01-24
Last Update Post Date Type:
ACTUAL